» Articles » PMID: 30888674

Uterine Fibroids - Current Trends and Strategies

Overview
Date 2019 Mar 20
PMID 30888674
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Fibroids are the most common benign tumors in women of childbearing age and can be found in almost 80-90% of all women by age 50 years. They can cause pain, excessive menstrual bleeding or infertility. The development of fibroids increases with age. Since the age of women in industrial countries who are trying to conceive is generally increasing, there has been a growing demand for minimally invasive and uterine-sparing surgical treatment of fibroids. Whereas the main focus of previous surgical techniques for the treatment of fibroids was enucleation of the tumour with subsequent closure of the uterine incision, modern devices developed over the past decade can destroy fibroids by using ultrasound or radio-frequency without incising the uterine wall. Thus, there is no uterine scar, which would impart a risk of rupture during labour or pregnancy. This article provides an overview of the latest techniques and devices used for uterine-sparing surgical treatment of fibroids. While laparoscopic myomectomy is still the gold standard, novel laparoscopic and transcervical radiofrequency ablation techniques use low-voltage and alternating current to induce heat in the uterine tissue, which triggers necrosis in fibroids. This enables the removal of multiple fibroids without the need for large incisions in the uterine wall. In addition, we address the benefits and potential risks, as well as the impact on fertility and pregnancy, of the different surgical approaches used for the treatment of uterine fibroids.

Citing Articles

Progress in High Intensity Focused Ultrasound Ablation for Fertility Preservation Therapy of Uterine Fibroids and Adenomyosis.

Zhang G, Li L, Sun M, Yu X Reprod Sci. 2024; 32(1):15-25.

PMID: 39532767 PMC: 11729086. DOI: 10.1007/s43032-024-01745-y.


Analysis of Expression of the ANG1, CaSR and FAK Proteins in Uterine Fibroids.

Markowska A, de Mezer M, Kurzawa P, Bednarek W, Grybos A, Krzyzaniak M Int J Mol Sci. 2024; 25(13).

PMID: 39000274 PMC: 11241732. DOI: 10.3390/ijms25137164.


The Appropriate Criteria in Patients Selection for Myomectomy in the Era of Minimally Invasive Surgery: A Case Report.

Jha S, Sonia , Sinha H, Sinha U J Reprod Infertil. 2022; 23(4):310-313.

PMID: 36452197 PMC: 9674465. DOI: 10.18502/jri.v23i4.10818.


Uterine fibroids increase the risk of preterm birth and other adverse birth events: a systematic review and meta-analysis.

Wang X, Wang G, Han R, Gao M, Wang F, Hong Y Transl Pediatr. 2022; 11(6):978-986.

PMID: 35800281 PMC: 9253953. DOI: 10.21037/tp-22-215.


Inhibiting effect of miR-29 on proliferation and migration of uterine leiomyoma via the STAT3 signaling pathway.

Huang D, Xue H, Shao W, Wang X, Liao H, Ye Y Aging (Albany NY). 2022; 14(3):1307-1320.

PMID: 35113040 PMC: 8876902. DOI: 10.18632/aging.203873.